CA

Sylvain Cloutier

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Université De Lausanne. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvain Cloutier. Retrieved from https://idiyas.com/inventor/sylvain-cloutier-8sefnr5l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sylvain Cloutier: Innovator in Protease Inhibition

Introduction

Sylvain Cloutier is a notable inventor based in Canada, recognized for his contributions to the field of protease inhibition. His innovative work has led to the development of a unique chimeric inhibitor protein that has significant implications in biochemistry and molecular biology.

Latest Patents

Cloutier holds a patent for "Inhibitor proteins of a protease and use thereof." This invention relates to a chimeric inhibitor protein of a protease, which comprises an inhibiting polypeptidic sequence and at least one polypeptidic sequence of a substrate-enzyme interaction site specific for a protease. The patent also includes a purified and isolated DNA sequence encoding the chimeric inhibitor protein, an expression vector containing this DNA sequence, and a method for producing the chimeric inhibitor protein.

Career Highlights

Sylvain Cloutier has made significant strides in his career, particularly through his work at the Université de Lausanne. His research focuses on the intricate mechanisms of protease inhibition, contributing valuable knowledge to the scientific community.

Collaborations

Cloutier has collaborated with David Deperthes, enhancing the scope and impact of his research endeavors.

Conclusion

Sylvain Cloutier's innovative work in the field of protease inhibition exemplifies the importance of research and development in advancing scientific knowledge. His contributions continue to influence the study of proteases and their inhibitors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…